mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.03 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.04 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.04 |
mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.092 |
0.05 |
mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.05 |